No new antidepressants likely in next decade, say scientists NHS and healthcare providers don’t want to foot the bill for expensive drugs so pharmaceuticals unwilling to invest in research
No new drugs for depression are likely in the next decade, even though those like Prozac work for little more than half of those treated and there have been concerns over their side effects, say scientists.
Leading psychiatrists, some of whom have been involved in drug development, say criticism of the antidepressants of the Prozac class, called the SSRIs (selective serotonin reuptake inhibitors), is partly responsible for the pharmaceutical industry’s reluctance to invest in new drugs – even though demand is steadily rising. Continue reading... The Guardian
See also:
No new drugs for depression are likely in the next decade, even though those like Prozac work for little more than half of those treated and there have been concerns over their side effects, say scientists.
Leading psychiatrists, some of whom have been involved in drug development, say criticism of the antidepressants of the Prozac class, called the SSRIs (selective serotonin reuptake inhibitors), is partly responsible for the pharmaceutical industry’s reluctance to invest in new drugs – even though demand is steadily rising. Continue reading... The Guardian
See also:
No comments:
Post a Comment